Pivotal Study Validates Roche's Cobas® HPV Test With HPV-16 And 18 Genotyping For Identifying Women At Highest Risk For Cervical Cancer
Links shared publicly online about this topic.
- 480total visits
Pivotal Study Validates Roche's Cobas® HPV Test With HPV-16 And 18 Genotyping For Identifying Women At Highest Risk For Cervical Cancer
View full resource at medicalnewstoday.com
Tags: Wart, STD, HPV, Cancer, Cervical Cancer, Cervical Cancer Prevention, HPV Test, Women's Health
Most Recently Shared on February 25, 2011 at 8:08 pm By:
Pivotal Study Validates Roche's Cobas® HPV Test With HPV-16 And 18 Genotyping For Identifying Women At Highest ... http://bit.ly/htgvc4
Also Shared By:
Pivotal Study Validates Roche's Cobas(R) HPV Test With HPV-16 And 18 Genotyping For Identifying Women In The UK At Highest Risk For Cervical Cancer
medicalnewstoday.com — “Roche announced today that a recent study published online in the American Journal of Clinical Pathology demonstrated the ability of the cobas® Human Papillomavirus (HPV) Test to indivi” View full resource at medicalnewstoday.com
Most Recently Shared on April 1, 2011 at 7:39 pm By:
Pivotal Study Validates Roche's Cobas(R) HPV Test With HPV-16 And 18 Genotyping For Identifying Women In The UK ... http://bit.ly/glT67h
Pivotal Study Validates Roche's Cobas(R) HPV Test With HPV-16 And 18 Genotyping For Identifying Women In The UK At Highest Risk For Cervical Cancer
medicalnewstoday.com — “Roche announced today that a recent study published online in the American Journal of Clinical Pathology demonstrated the ability of the cobas® Human Papillomavirus (HPV) Test to indivi” View full resource at medicalnewstoday.com
Most Recently Shared on April 1, 2011 at 3:05 pm By:
MNT Cervical Cancer Health News
Pivotal Study Validates Roche's Cobas(R) HPV Test With HPV-16 And 18 Genotyping For Identifying Women In The UK At Hig... http://mnt.to/3T4v
Roche - Pivotal Study Validates Roche's cobas HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer
roche.com — “Roche - Pivotal Study Validates Roche's cobas HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer” View full resource at roche.com
Most Recently Shared on February 25, 2011 at 7:48 am By:
Pivotal Study Validates Roche’s cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women with... http://cot.ag/eetN8C #RocheIR
Pivotal Study Validates Roche's cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer - Health News - redOrbit
redorbit.com — “ATHENA study shows the cobas HPV Test advances the standard of care by providing valuable information on the risks associated with the genotypes which cause 70 percent of cervical cancer PLEASANTON, Calif., Feb.” View full resource at redorbit.com
Most Recently Shared on February 25, 2011 at 2:24 am By:
Pivotal Study Validates Roche's cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest R... http://bit.ly/ij0g7z
Advertisement
Drugs and Devices OW
@Drugs_Devices
Pivotal Study Validates Roche's Cobas® HPV Test With HPV-16 And 18 Genotyping For Identifying Women A... http://mnt.to/f/3RBS #MedDevice
1 year ago...